Next Article in Journal
Optimization of Methods for the Production and Refolding of Biologically Active Disulfide Bond-Rich Antibody Fragments in Microbial Hosts
Next Article in Special Issue
The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection
Previous Article in Journal
Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague Model
Previous Article in Special Issue
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry

Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?

Academic Department of Obstetrics & Gynaecology, Imperial College London, Level 3, Chelsea & Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK
Author to whom correspondence should be addressed.
Antibodies 2020, 9(3), 38;
Received: 31 May 2020 / Revised: 6 July 2020 / Accepted: 21 July 2020 / Published: 4 August 2020
The intricacy of the maternal immune system arises from its ability to prevent a maternal immune response against a semi-allogenic fetus, while protecting the mother against harmful pathogens. However, these immunological adaptations may also make pregnant women vulnerable to developing adverse complications from respiratory viral infections. While the influenza and SARS pandemics support this theory, there is less certainty regarding the clinical impact of SARS-CoV-2 in pregnancy. In the current COVID-19 pandemic, vaccine development is key to public preventative strategies. Whilst most viral vaccines are able to induce a seroprotective antibody response, in some high-risk individuals this may not correlate with clinical protection. Some studies have shown that factors such as age, gender, and chronic illnesses can reduce their effectiveness and in this review, we discuss how pregnancy may affect the efficacy and immunogenicity of vaccines. We present literature to support the hypothesis that pregnant women are more susceptible to respiratory viral infections and may not respond to vaccines as effectively. In particular, we focus on the clinical implications of important respiratory viral infections such as influenza during pregnancy, and the pregnancy induced alterations in important leukocytes such as TFH, cTFH and B cells, which play an important role in generating long-lasting and high-affinity antibodies. Finally, we review how this may affect the efficacy of vaccines against influenza in pregnancy and highlight areas that require further research. View Full-Text
Keywords: influenza; vaccine; pregnancy; antibodies; B cell influenza; vaccine; pregnancy; antibodies; B cell
Show Figures

Graphical abstract

MDPI and ACS Style

Saeed, Z.; Greer, O.; Shah, N.M. Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy? Antibodies 2020, 9, 38.

AMA Style

Saeed Z, Greer O, Shah NM. Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy? Antibodies. 2020; 9(3):38.

Chicago/Turabian Style

Saeed, Zainab, Orene Greer, and Nishel M. Shah 2020. "Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?" Antibodies 9, no. 3: 38.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop